Antiviral Therapy in Infants With HBV Infection

NCT06503796 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HBV

Interventions

DRUG: Lamivudine
DRUG: Interferon

Sponsor

Beijing 302 Hospital